U.S, November 27, 2019 (HEMPGAZETTE) A recent study out of Washington State University indicates inhaled cannabis may reduce the intensity of headaches and migraines.
Led by Carrie Cuttler, a WSU assistant professor of psychology, a research term analyzed information submitted by more than 1,300 patients who used the Strainprint app...
AUSTRALIAN, January 21, 2020 (HEMPGAZETTE) There’s a lot of activity on the Australian cannabusiness scene, but what is happening at the patient end of things? Statistics from the Therapeutic Goods Administration (TGA) indicate significant growth in approvals, but it wouldn’t even be touching the sides of potential...
U.S, November 27, 2019 (ANALYTICALCANNABIS) Cannabis may be a promising alternative for chronic pain sufferers who are turning to illicit opioids to manage their symptoms, according to the results of a new study.
Previous scientific studies have documented the behavior of chronic pain patients who are using cannabis as an alternative pain...
U.S, February 10, 2020 (GREENMARKETREPORT) Cannabis, to some, is seen as a risky market. Bankers, the government, and society, in general, all have their own hesitations with the industry. This rings true for investors, too. FINANCIAL-investors-tell-cannabis-companies-prove-it-before-opening-wallet
Some financial experts are adamant about the importance...
The 400-plus chemical compounds in cannabis have the potential to treat more than a dozen medical conditions. Cannabinoids are the most abundant molecules, and scientists have identified over 100 of them.
Medical professionals and other researchers are still in the infancy stage of cannabinoid medicine. However, the current data is...
The potential of therapeutic cannabis is real. Since 1995, there have been over 25,000 peer-reviewed articles in various medical journals in the U.S. and around the world about the plant’s medicinal characteristics and potential for therapeutic use. Also during that time, over 30 states have approved medical cannabis programs...